La úlcera de etiología venosa es la más prevalente de las úlceras de extremidad inferior. Entre el 75 y el 80% de las úlceras de la extremidad inferior son de esta etiología. De acuerdo con las evidencias disponibles, el tratamiento de las úlceras de etiología venosa tiene como base dos grandes pilares: el manejo de la úlcera como una herida crónica y el control de la hipertensión venosa crónica (HTV), su causa primordial, mediante sistemas de alta compresión decreciente y mantenida. De todos los métodos de control de la HTV, el sistema multicapa ha demostrado clínicamente que permite alcanzar un 80% de tasa de cicatrización de lesiones a las doce semanas de tratamiento, erigiéndose como el tratamiento más efectivo de los existentes hasta el momento. Por otro lado, a menudo, una compresión de 40 mm Hg en el tobillo no es bien tolerada por todas las personas afectadas de HTV crónica. Para esos casos rebeldes en los que debemos utilizar recursos alternativos, nosotros hemos utilizado la cromoterapia ya que ha demostrado, mediante varios estudios, ser útil en la curación de heridas consiguiendo, entre otros beneficios, estimular el aporte sanguíneo al lecho de la herida, favoreciendo así la oxigenación. En base a estos hechos, nos planteamos la aplicabilidad de la cromoterapia en la cura de las ulceras venosas, como tratamiento complementario a las curas habituales, cuando estos no son lo suficientemente efectivos o cuando el paciente no tolera el vendaje elástico multicapa.
The aim of this study is to assess the influence of living in nursing homes on COVID-19-related mortality, and to calculate the real specific mortality rate caused by COVID-19 among people older than 20 years of age in the Balaguer Primary Care Centre Health Area during the first wave of the pandemic. We conducted an observational study based on a database generated between March and May 2020, analysing COVID-19-related mortality as a dependent variable, and including different independent variables, such as living in a nursing home or in the community (outside nursing homes), age, sex, symptoms, pre-existing conditions, and hospital admission. To evaluate the associations between the independent variables and mortality, we calculated the absolute and relative frequencies, and performed a chi-square test. To avoid the impact of the age variable on mortality and to assess the influence of the “living in a nursing home” variable, we established comparisons between infected population groups over 69 years of age (in nursing homes and outside nursing homes). Living in a nursing home was associated with a higher incidence of COVID-19 infection, but not with higher mortality in patients over 69 years of age (p = 0.614). The real specific mortality rate caused by COVID-19 was 2.270/00. In the study of the entire sample, all the comorbidities studied were associated with higher mortality; however, the comorbidities were not associated with higher mortality in the infected nursing home patients group, nor in the infected community patients over 69 years of age group (except for neoplasm history in this last group). Finally, hospital admission was not associated with lower mortality in nursing home patients, nor in community patients over 69 years of age.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.